Hoffmann G, Preibisch C, Gunther M, Mahroo A, van Osch M, Vaclavu L
Magn Reson Med. 2025; 93(5):2086-2098.
PMID: 39777739
PMC: 11893035.
DOI: 10.1002/mrm.30415.
Gao L, Li Y, Zhu H, Liu Y, Li S, Li L
Cancer Imaging. 2024; 24(1):134.
PMID: 39385297
PMC: 11462830.
DOI: 10.1186/s40644-024-00782-9.
Kohli J, Reyes A, Hopper A, Stasenko A, Menendez N, Tringale K
Neurooncol Adv. 2024; 6(1):vdae152.
PMID: 39359697
PMC: 11445899.
DOI: 10.1093/noajnl/vdae152.
Schubert M, Soyka S, Tamimi A, Maus E, Schroers J, Wissmann N
Nat Commun. 2024; 15(1):7383.
PMID: 39256378
PMC: 11387418.
DOI: 10.1038/s41467-024-51432-4.
Fels-Palesandro H, Heuer S, Boztepe B, Streibel Y, Ungermann J, Pan C
J Magn Reson Imaging. 2024; 61(3):1203-1218.
PMID: 39177509
PMC: 11803692.
DOI: 10.1002/jmri.29567.
Challenges with segmenting intraoperative ultrasound for brain tumours.
Weld A, Dixon L, Anichini G, Patel N, Nimer A, Dyck M
Acta Neurochir (Wien). 2024; 166(1):317.
PMID: 39090435
PMC: 11294268.
DOI: 10.1007/s00701-024-06179-8.
EZH2-STAT3 signaling pathway regulates GSDMD-mediated pyroptosis in glioblastoma.
Yu D, Wang S, Wang J, Zhang K, Niu Z, Lin N
Cell Death Discov. 2024; 10(1):341.
PMID: 39069522
PMC: 11284224.
DOI: 10.1038/s41420-024-02105-0.
Combination of MRI-based prediction and CRISPR/Cas12a-based detection for IDH genotyping in glioma.
Yu D, Zhong Q, Xiao Y, Feng Z, Tang F, Feng S
NPJ Precis Oncol. 2024; 8(1):140.
PMID: 38951603
PMC: 11217299.
DOI: 10.1038/s41698-024-00632-8.
Cavitation monitoring, treatment strategy, and acoustic simulations of focused ultrasound blood-brain barrier disruption in patients with glioblastoma.
McDannold N, Wen P, Reardon D, Fletcher S, Golby A
J Control Release. 2024; 372:194-208.
PMID: 38897294
PMC: 11299340.
DOI: 10.1016/j.jconrel.2024.06.036.
CRISPRi screen of long non-coding RNAs identifies LINC03045 regulating glioblastoma invasion.
Tsung K, Liu K, Han J, Deshpande K, Doan T, Loh Y
PLoS Genet. 2024; 20(6):e1011314.
PMID: 38857306
PMC: 11192328.
DOI: 10.1371/journal.pgen.1011314.
Advanced diffusion MRI provides evidence for altered axonal microstructure and gradual peritumoral infiltration in GBM in comparison to brain metastases.
Wurtemberger U, Rau A, Diebold M, Becker L, Hohenhaus M, Beck J
Clin Neuroradiol. 2024; 34(3):703-711.
PMID: 38683350
PMC: 11339137.
DOI: 10.1007/s00062-024-01416-0.
Preoperative growth dynamics of untreated glioblastoma: Description of an exponential growth type, correlating factors, and association with postoperative survival.
Feucht D, Haas P, Skardelly M, Behling F, Rieger D, Bombach P
Neurooncol Adv. 2024; 6(1):vdae053.
PMID: 38680987
PMC: 11046984.
DOI: 10.1093/noajnl/vdae053.
Principles in the Management of Glioblastoma.
Roda D, Veiga P, Melo J, Carreira I, Ribeiro I
Genes (Basel). 2024; 15(4).
PMID: 38674436
PMC: 11050118.
DOI: 10.3390/genes15040501.
Effects of Tetrahydrolipstatin on Glioblastoma in Mice: MRI-Based Morphologic and Texture Analysis Correlated with Histopathology and Immunochemistry Findings-A Pilot Study.
Wagner S, Ewald C, Freitag D, Herrmann K, Koch A, Bauer J
Cancers (Basel). 2024; 16(8).
PMID: 38672673
PMC: 11048907.
DOI: 10.3390/cancers16081591.
PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma.
Heuer S, Burghaus I, Gose M, Kessler T, Sahm F, Vollmuth P
BMC Cancer. 2024; 24(1):135.
PMID: 38279087
PMC: 10811925.
DOI: 10.1186/s12885-024-11846-1.
A New Systemic Disease Mouse Model for Glioblastoma Capable of Single-Tumour-Cell Detection.
Ware T, Luwor R, Zhu H
Cells. 2024; 13(2).
PMID: 38275817
PMC: 10814551.
DOI: 10.3390/cells13020192.
Cortical myelin and thickness mapping provide insights into whole-brain tumor burden in diffuse midline glioma.
Zhang S, Yang X, Tan Q, Sun H, Chen D, Chen Y
Cereb Cortex. 2023; 34(1).
PMID: 38112602
PMC: 10793579.
DOI: 10.1093/cercor/bhad491.
Current Knowledge about the Peritumoral Microenvironment in Glioblastoma.
Trevisi G, Mangiola A
Cancers (Basel). 2023; 15(22).
PMID: 38001721
PMC: 10670229.
DOI: 10.3390/cancers15225460.
Efficacy of combined tumor irradiation and K3.1-targeting with TRAM-34 in a syngeneic glioma mouse model.
Stransky N, Ganser K, Quintanilla-Martinez L, Gonzalez-Menendez I, Naumann U, Eckert F
Sci Rep. 2023; 13(1):20604.
PMID: 37996600
PMC: 10667541.
DOI: 10.1038/s41598-023-47552-4.
Mesoscopic Assessment of Microstructure in Glioblastomas and Metastases by Merging Advanced Diffusion Imaging with Immunohistopathology.
Wurtemberger U, Erny D, Rau A, Hosp J, Akgun V, Reisert M
AJNR Am J Neuroradiol. 2023; 44(11):1262-1269.
PMID: 37884304
PMC: 10631536.
DOI: 10.3174/ajnr.A8022.
